Overview
Aplasia of lacrimal and salivary glands represents a rare developmental anomaly with significant clinical implications, particularly concerning oral health and tear production. This condition can manifest as isolated defects or in association with broader ectodermal dysplasia syndromes. The rarity and variability in presentation necessitate a thorough understanding of its pathophysiology, clinical manifestations, diagnostic approaches, and management strategies. This guideline synthesizes current evidence to provide clinicians with a comprehensive framework for recognizing and managing patients with these anomalies.
Pathophysiology
Aplasia of the lacrimal and salivary glands arises from disruptions in embryonic development, specifically affecting the ectodermal tissues responsible for gland formation. A notable case report detailed bilateral aplasia of the parotid glands alongside the presence of accessory parotid tissue, without any other congenital anomalies [PMID:16623979]. This suggests that while the primary glands may be absent, compensatory mechanisms might exist in some individuals. The underlying genetic mechanisms remain incompletely understood, though some cases have been linked to mutations in genes involved in ectodermal development, such as FGF10, FGFR2, and FGFR3 [PMID:35076829]. These genes play crucial roles in the signaling pathways essential for glandular differentiation and growth, indicating that disruptions in these pathways can lead to glandular aplasia. Despite these insights, the exact etiology often remains elusive without comprehensive genetic analysis.
Epidemiology
Salivary gland aplasia is exceedingly rare, with a comprehensive literature review identifying only 148 reported cases [PMID:35076829]. The median age at diagnosis is approximately 21 years, highlighting that many cases may go undetected until adulthood. Interestingly, one-third of these cases are asymptomatic, underscoring the potential for underdiagnosis due to lack of overt symptoms [PMID:35076829]. Congenital aplasia of major salivary glands frequently occurs in the context of ectodermal dysplasia syndromes, which encompass a spectrum of developmental anomalies affecting structures derived from the ectoderm, including skin, hair, nails, teeth, and glands [PMID:21703060]. However, isolated cases without associated syndromes are also documented, emphasizing the heterogeneous nature of this condition.
Clinical Presentation
The clinical presentation of lacrimal and salivary gland aplasia varies widely, depending on the specific glands affected and the presence or absence of associated syndromes. A 64-year-old woman with bilateral parotid gland aplasia presented without craniofacial abnormalities and maintained a full set of teeth without active caries, suggesting compensatory mechanisms in salivary function [PMID:35076829]. Conversely, a 10-year-old boy with bilateral aplasia of both submandibular and parotid glands exhibited significant xerostomia, leading to increased risks of dental caries and infections [PMID:21703060]. These cases illustrate the spectrum of clinical outcomes, from asymptomatic to severely symptomatic presentations. Patients often report symptoms related to reduced tear production (dry eyes) and salivary insufficiency (dry mouth, difficulty swallowing, and increased susceptibility to oral infections). The variability underscores the importance of a thorough clinical history and examination to identify these anomalies early.
Diagnosis
Diagnosing aplasia of lacrimal and salivary glands requires a multi-modal approach combining clinical evaluation with advanced imaging techniques. Radiographic imaging, including panoramic radiographs, computed tomography (CT), and magnetic resonance imaging (MRI), plays a pivotal role in confirming the absence of glandular structures [PMID:35076829]. Panoramic radiographs can initially suggest abnormalities in glandular morphology, while CT and MRI provide detailed anatomical confirmation. In some cases, genetic testing may be warranted to rule out associated syndromes. Sequence analysis of genes such as FGF10, FGFR2, and FGFR3 can exclude pathogenic variants that might explain the condition in the context of broader syndromes [PMID:35076829]. Early diagnosis is crucial, as it allows for timely intervention to mitigate complications such as severe dental caries and infections, which are common in symptomatic patients [PMID:21703060].
Differential Diagnosis
When evaluating a patient for salivary gland aplasia, clinicians must consider several differential diagnoses that can present with similar symptoms or imaging findings. Conditions such as Sjögren's syndrome, radiation-induced salivary gland damage, and congenital anomalies like DiGeorge syndrome should be ruled out. Genetic testing, particularly focusing on genes implicated in ectodermal development, can help differentiate isolated aplasia from syndromic presentations [PMID:35076829]. Clinical correlation with systemic symptoms and additional imaging modalities (e.g., sialography, scintigraphy) may further refine the diagnosis by assessing functional aspects of remaining glandular tissue.
Management
Management of lacrimal and salivary gland aplasia primarily focuses on mitigating the consequences of glandular insufficiency, particularly xerostomia and its associated complications. Preventive and restorative dental care is essential for patients experiencing oral health issues. This includes regular dental check-ups, fluoride treatments, and possibly salivary stimulants or artificial saliva substitutes to maintain oral moisture [PMID:21703060]. For patients with severe xerostomia, systemic measures such as pilocarpine or cevimulan may be considered to stimulate residual glandular function [PMID:21703060]. Additionally, addressing dry eye symptoms with artificial tears or other ocular lubricants is crucial for maintaining ocular comfort and preventing corneal damage. Regular follow-up is necessary to monitor for evolving complications and adjust management strategies accordingly.
Complications
The most significant complications arising from lacrimal and salivary gland aplasia are directly related to the functional deficits caused by glandular insufficiency. Xerostomia significantly increases the risk of dental caries, periodontal disease, and oral infections, necessitating rigorous oral hygiene practices and frequent dental interventions [PMID:21703060]. In the ocular domain, insufficient tear production can lead to chronic dry eye syndrome, potentially causing corneal ulceration, infections, and visual impairment if left untreated. These complications underscore the importance of proactive management and regular monitoring to prevent long-term sequelae.
Prognosis & Follow-up
The prognosis for patients with lacrimal and salivary gland aplasia varies based on the severity of symptoms and the effectiveness of management strategies. Many cases remain asymptomatic, leading to potential underdiagnosis and delayed intervention [PMID:35076829]. Systematic reporting and increased awareness among clinicians are essential to better understand the true prevalence and natural history of this condition. Regular follow-up appointments are crucial for monitoring oral and ocular health, adjusting treatments as needed, and addressing any emerging complications promptly. Early intervention can significantly improve quality of life and prevent severe long-term consequences associated with glandular insufficiency.
Key Recommendations
References
1 Kuralt H, Fidler A, Blatnik A, Novaković S, Plavc G. Bilateral parotid glands aplasia: a case report and literature review. Oral radiology 2022. link 2 Taji SS, Savage N, Holcombe T, Khan F, Seow WK. Congenital aplasia of the major salivary glands: literature review and case report. Pediatric dentistry 2011. link 3 Antoniades DZ, Markopoulos AK, Deligianni E, Andreadis D. Bilateral aplasia of parotid glands correlated with accessory parotid tissue. The Journal of laryngology and otology 2006. link
3 papers cited of 4 indexed.